X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

TARS

Closed

Tarsus Pharmaceuticals inc

39.99
-0.52 (-1.28%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 40.51
Day's Range: 39.19 - 41.03
Send
When Written:
 
12.18
Tarsus Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that focuses on developing and commercializing innovative therapies for ophthalmic diseases. The company's lead product candidate, TP-03, is a novel antibiotic and anti-inflammatory combination therapy designed to treat blepharitis, a common eye condition that affects the eyelids. Tarsus Pharmaceuticals was founded in 2017 and is headquartered in Irvine, California. The company went public in August 2020 and is listed on the NASDAQ stock exchange under the ticker symbol TARS.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X